P, S., M, J., P, S., K, S., T, B., C, S., . . . N, G. (2022). Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein‒Barr Virus and Cytomegalovirus Infection. The Journal of investigative dermatology, 142(3 Pt A), 549. https://doi.org/10.1016/j.jid.2021.07.171
Chicago Style (17th ed.) CitationP, Speth, et al. "Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein‒Barr Virus and Cytomegalovirus Infection." The Journal of Investigative Dermatology 142, no. 3 Pt A (2022): 549. https://doi.org/10.1016/j.jid.2021.07.171.
MLA (9th ed.) CitationP, Speth, et al. "Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein‒Barr Virus and Cytomegalovirus Infection." The Journal of Investigative Dermatology, vol. 142, no. 3 Pt A, 2022, p. 549, https://doi.org/10.1016/j.jid.2021.07.171.